Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.44 USD
Change Today +0.0195 / 4.64%
Volume 307.8K
OPXA On Other Exchanges
As of 8:10 PM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Neil K. Warma

Chief Executive Officer, President and Director,Opexa Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 22 board members in 2 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Neil K. Warma has been the Chief Executive Officer and President of Opexa Therapeutics, Inc., since June 16, 2008 and served as its Secretary. Mr. Warma served as an Acting Chief Financial Officer and Principal Accounting Officer of Opexa Therapeutics Inc., since March 2009 until August 15, 2012. He served as the Chief Executive Officer and President of Viron Therapeutics Inc. from 2004 to August 2007. While at Viron, Mr. Warma oversaw the launch of its first Phase ...

Read Full Background

Corporate Headquarters*

2635 Technology Forest Boulevard
The Woodlands, Texas 77381

United States

Phone: 281-272-9331
Fax: 281-872-8585

Board Members Memberships*

Chief Executive Officer, President and Director


Honors Degree
University of Toronto
Schulich School Of Business At York University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$579,211

Stock Options*

Restricted Stock Awards$94,181
Exercisable Options305,774
Unexercisable Options703,693
Total Number of Options1,009,467

Total Compensation*

Total Annual Cash Compensation$579,211
Total Short Term Compensation$579,211
Other Long Term Compensation$94,181
Total Calculated Compensation$1,810,749
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OPXA:US $0.44 USD +0.0195


Martin M. McGlynn Chief Executive Officer, Director, Member of Strategic Transactions Committee, Chief Executive Officer of Stemcells California Inc and President of Stemcells California Inc
StemCells Inc.
David J. Mazzo B.A (Hons), B.Sc. (Hons.), M.Sc., Ph.D.Chief Executive Officer and Director
Caladrius Biosciences, Inc.
Weidong Yin Chairman, Chief Executive Officer, President, Managing Director, Secretary, Chairman of Sinovac Hong Kong, Chairman of Tangshan Yian, Chairman of Sinovac Dalian and Director of Sinovac Biotech Co
Sinovac Biotech Ltd.
Zhilin Li Chairman, Chief Executive Officer, President and Interim Chief Financial Officer
China Pharma Holdings, Inc.
Guoqing Jiang M.D.Chairman, Chief Executive Officer, President, Acting Chief Financial Officer and Chief Accounting Officer
Tianyin Pharmaceutical Co., Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OPEXA THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at